RATIONALE: Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the
enzymes needed for cell growth or by blocking blood flow to the tumor. Drugs used in
chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth
of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This randomized phase I/II trial is studying the side effects and best dose of
pazopanib hydrochloride when given together with paclitaxel and carboplatin in treating
patients with refractory or resistant ovarian epithelial cancer, fallopian tube cancer, or
peritoneal cancer.
Jul 31,2012
Female
18 Years
N/A
18 Years
N/A
88